Literature DB >> 22159678

Cellular inflammation in nonarteritic anterior ischemic optic neuropathy and its primate model.

Cristian Salgado1, Fernandino Vilson, Neil R Miller, Steven L Bernstein.   

Abstract

OBJECTIVE: To correlate potential inflammatory responses in nonarteritic anterior ischemic optic neuropathy (NAION) with a lesion possessing many physiologic and histologic similarities from a model of nonhuman primate NAION (pNAION).
METHODS: Using immunohistochemistry and confocal microscopic analysis, we evaluated the relative numbers of inflammatory cell types in the single available clinical specimen of early NAION (21 days after event). We correlated this with the temporal inflammatory response occurring in optic nerve tissue at different times following pNAION induction.
RESULTS: In pNAION, there is a previously unsuspected infiltration of polymorphonuclear leukocytes occurring almost immediately after infarct induction, followed by invasion of ED1+ extrinsic macrophages, which peaks 5 weeks after infarct. Intrinsic microglia accumulate up to 70 days after induction in the area of primary axonal loss. The analyzed human NAION specimen was similar to 21-day pNAION tissue, with extrinsic macrophages and intrinsic microglial cells in the region of focal axon loss.
CONCLUSIONS: Cellular inflammation plays a major early role following white-matter (optic nerve) infarct, with both polymorphonuclear leukocyte and macrophage function involved in debris elimination and tissue remodeling. The optic nerve in NAION and its primate model are associated with early cellular inflammation, previously unsuspected, that may contribute to postinfarct optic nerve damage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22159678      PMCID: PMC3494739          DOI: 10.1001/archophthalmol.2011.351

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  31 in total

1.  Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment.

Authors:  J Priller; A Flügel; T Wehner; M Boentert; C A Haas; M Prinz; F Fernández-Klett; K Prass; I Bechmann; B A de Boer; M Frotscher; G W Kreutzberg; D A Persons; U Dirnagl
Journal:  Nat Med       Date:  2001-12       Impact factor: 53.440

2.  Characterization of activated retinal microglia following optic axotomy.

Authors:  Cheng Zhang; Mark O M Tso
Journal:  J Neurosci Res       Date:  2003-09-15       Impact factor: 4.164

3.  Incidence of nonarteritic anterior ischemic optic neuropathy.

Authors:  M G Hattenhauer; J A Leavitt; D O Hodge; R Grill; D T Gray
Journal:  Am J Ophthalmol       Date:  1997-01       Impact factor: 5.258

4.  Turnover of rat brain perivascular cells.

Authors:  I Bechmann; E Kwidzinski; A D Kovac; E Simbürger; T Horvath; U Gimsa; U Dirnagl; J Priller; R Nitsch
Journal:  Exp Neurol       Date:  2001-04       Impact factor: 5.330

5.  Optic nerve infarction and post-ischemic inflammation in the rodent model of anterior ischemic optic neuropathy (rAION).

Authors:  Cheng Zhang; Yan Guo; Neil R Miller; Steven L Bernstein
Journal:  Brain Res       Date:  2009-01-15       Impact factor: 3.252

Review 6.  Corticosteroids for acute ischaemic stroke.

Authors:  N Qizilbash; S L Lewington; J M Lopez-Arrieta
Journal:  Cochrane Database Syst Rev       Date:  2002

7.  Temporal and spatial dynamics of cerebral immune cell accumulation in stroke.

Authors:  Mathias Gelderblom; Frank Leypoldt; Karin Steinbach; Doerthe Behrens; Chi-Un Choe; Dominic A Siler; Thiruma V Arumugam; Ellen Orthey; Christian Gerloff; Eva Tolosa; Tim Magnus
Journal:  Stroke       Date:  2009-03-05       Impact factor: 7.914

8.  Non-arteritic anterior ischemic optic neuropathy: role of systemic corticosteroid therapy.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-04-11       Impact factor: 3.117

9.  Overcoming macrophage-mediated axonal dieback following CNS injury.

Authors:  Sarah A Busch; Kevin P Horn; Daniel J Silver; Jerry Silver
Journal:  J Neurosci       Date:  2009-08-12       Impact factor: 6.167

10.  A primate model of nonarteritic anterior ischemic optic neuropathy.

Authors:  Celia S Chen; Mary A Johnson; Robert A Flower; Bernard J Slater; Neil R Miller; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-07       Impact factor: 4.799

View more
  31 in total

Review 1.  Neutrophil-to-lymphocyte ratio in ocular diseases: a systematic review.

Authors:  Bengi Ece Kurtul; Pinar Altiaylik Ozer
Journal:  Int J Ophthalmol       Date:  2019-12-18       Impact factor: 1.779

2.  A Single Intravitreal Injection of Ranibizumab Provides No Neuroprotection in a Nonhuman Primate Model of Moderate-to-Severe Nonarteritic Anterior Ischemic Optic Neuropathy.

Authors:  Neil R Miller; Mary A Johnson; Theresa Nolan; Yan Guo; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

3.  Optical coherence tomography study of experimental anterior ischemic optic neuropathy and histologic confirmation.

Authors:  Joyce K Ho; Madison P Stanford; Mohammad A Shariati; Roopa Dalal; Yaping Joyce Liao
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-05       Impact factor: 4.799

Review 4.  Ischemic optic neuropathies - where are we now?

Authors:  Sohan Singh Hayreh
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-07-03       Impact factor: 3.117

5.  Sustained neuroprotection from a single intravitreal injection of PGJ₂ in a nonhuman primate model of nonarteritic anterior ischemic optic neuropathy.

Authors:  Neil R Miller; Mary A Johnson; Theresa Nolan; Yan Guo; Alexander M Bernstein; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-10-08       Impact factor: 4.799

Review 6.  Ischemic optic neuropathies and their models: disease comparisons, model strengths and weaknesses.

Authors:  Steven L Bernstein; Neil R Miller
Journal:  Jpn J Ophthalmol       Date:  2015-02-18       Impact factor: 2.447

7.  Current concepts in the diagnosis, pathogenesis and management of nonarteritic anterior ischaemic optic neuropathy.

Authors:  N R Miller; A C Arnold
Journal:  Eye (Lond)       Date:  2014-07-04       Impact factor: 3.775

8.  Neutrophil-to-Lymphocyte Ratio as a Marker in Patients with Non-arteritic Anterior Ischemic Optic Neuropathy.

Authors:  Onur Polat; Güliz Fatma Yavaş; Sibel İnan; Ümit Übeyt İnan
Journal:  Balkan Med J       Date:  2015-10-01       Impact factor: 2.021

9.  Sustained neuroprotection from a single intravitreal injection of PGJ2 in a rodent model of anterior ischemic optic neuropathy.

Authors:  Valerie Touitou; Mary A Johnson; Yan Guo; Neil R Miller; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-11       Impact factor: 4.799

10.  Optic nerve inflammation and demyelination in a rodent model of nonarteritic anterior ischemic optic neuropathy.

Authors:  Bernard J Slater; Fernandino L Vilson; Yan Guo; Daniel Weinreich; Shelly Hwang; Steven L Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.